-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PyULD88I7wX1YmUx1ZMBXUcqoNk1roy2xDlBj9WPBkaZnMs6209v5jkkSXCI6Wm8 rDzFLiOHoZ1OGdmMS5avaA== 0000950134-08-015870.txt : 20080827 0000950134-08-015870.hdr.sgml : 20080827 20080827170054 ACCESSION NUMBER: 0000950134-08-015870 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080827 DATE AS OF CHANGE: 20080827 GROUP MEMBERS: ANSBERT GADICKE GROUP MEMBERS: BAB BIOVENTURES LP GROUP MEMBERS: BAB BIOVENTURES NV GROUP MEMBERS: DENNIS HENNER GROUP MEMBERS: KURT WHEELER GROUP MEMBERS: LUKE EVNIN GROUP MEMBERS: MICHAEL STEINMETZ GROUP MEMBERS: MPM ASSET MANAGEMENT INVESTORS 1999 LLC GROUP MEMBERS: MPM ASSET MANAGEMENT INVESTORS 2004 BVIII LLC GROUP MEMBERS: MPM BIOVENTURES I LLC GROUP MEMBERS: MPM BIOVENTURES I LP GROUP MEMBERS: MPM BIOVENTURES III GMBH & CO BETEILIGUNGS KG GROUP MEMBERS: MPM BIOVENTURES III GP LP GROUP MEMBERS: MPM BIOVENTURES III LLC GROUP MEMBERS: MPM BIOVENTURES III LP GROUP MEMBERS: MPM BIOVENTURES III PARALLEL FUND LP GROUP MEMBERS: MPM BIOVENTURES III QP LP GROUP MEMBERS: MPM BIOVENTURES PARALLEL FUND LP GROUP MEMBERS: NICHOLAS GALAKATOS GROUP MEMBERS: NICHOLAS SIMON III FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BB BIOVENTURES L P CENTRAL INDEX KEY: 0001040662 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 62 DE RUYTURES CITY: CURACAO NETHERLANDS ANTILLES STATE: P8 MAIL ADDRESS: STREET 1: 111 HUNTINGTON AVE 31ST FL CITY: BOSTON STATE: MA ZIP: 02119 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Pharmasset Inc CENTRAL INDEX KEY: 0001301081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-82851 FILM NUMBER: 081042575 BUSINESS ADDRESS: STREET 1: 303-A COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-613-4100 MAIL ADDRESS: STREET 1: 303-A COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 SC 13G/A 1 f43396sc13gza.htm AMENDMENT TO SCHEDULE 13G sc13gza
     
 
OMB APPROVAL
 
 
OMB Number: 3235-0145
 
 
Expires: February 28, 2009
 
 
Estimated average burden hours per response...10.4
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
PHARMASSET, INC.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
71715N 10 6
(CUSIP Number)
August 11, 2008
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
o
  Rule 13d-1(b)
 
o
  Rule 13d-1(c)
 
þ
  Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 


 

                     
CUSIP No.
 
71715N 10 6 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
BB BioVentures, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 2 of 34


 

                     
CUSIP No.
 
71715N 10 6 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
MPM BioVentures Parallel Fund, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 3 of 34


 

                     
CUSIP No.
 
71715N 10 6 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
MPM Asset Management Investors 1999 LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO

Page 4 of 34


 

                     
CUSIP No.
 
71715N 10 6 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
MPM BioVentures III-QP, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 5 of 34


 

                     
CUSIP No.
 
71715N 10 6 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
MPM BioVentures III, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 6 of 34


 

                     
CUSIP No.
 
71715N 10 6 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
MPM BioVentures III GmbH & Co. Beteiligungs KG
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Germany
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 7 of 34


 

                     
CUSIP No.
 
71715N 10 6 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
MPM Asset Management Investors 2004 BVIII LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO

Page 8 of 34


 

                     
CUSIP No.
 
71715N 10 6 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
MPM BioVentures III Parallel Fund, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 9 of 34


 

                     
CUSIP No.
 
71715N 10 6 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
MPM BioVentures I, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 10 of 34


 

                     
CUSIP No.
 
71715N 10 6 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
MPM BioVentures I LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO

Page 11 of 34


 

                     
CUSIP No.
 
71715N 10 6 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
BAB BioVentures L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 12 of 34


 

                     
CUSIP No.
 
71715N 10 6 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
BAB BioVentures, N.V.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Cayman
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 13 of 34


 

                     
CUSIP No.
 
71715N 10 6 
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
MPM BioVentures III GP, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 14 of 34


 

                     
CUSIP No.
 
  71715N 10 6
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
MPM BioVentures III LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO

Page 15 of 34


 

                     
CUSIP No.
 
  71715N 10 6
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Ansbert Gadicke
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN

Page 16 of 34


 

                     
CUSIP No.
 
  71715N 10 6
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Luke Evnin
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN

Page 17 of 34


 

                     
CUSIP No.
 
  71715N 10 6
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Michael Steinmetz
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN

Page 18 of 34


 

                     
CUSIP No.
 
  71715N 10 6
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Kurt Wheeler
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN

Page 19 of 34


 

                     
CUSIP No.
 
  71715N 10 6
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Nicholas Galakatos
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN

Page 20 of 34


 

                     
CUSIP No.
 
  71715N 10 6
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Dennis Henner
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN

Page 21 of 34


 

                     
CUSIP No.
 
  71715N 10 6
 

 

           
1   NAME OF REPORTING PERSONS
I.R.S. Identification No(s). of above person(s) (entities only)
Nicholas Simon III
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  0
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN

Page 22 of 34


 

Item 1.
  (a)   Name of Issuer
 
      Pharmasset, Inc.
 
  (b)   Address of Issuer’s Principal Executive Offices
      303-A College Road East
Princeton, NJ 08540
Item 2.
  (a)   Name of Person Filing
BB BioVentures, LP
MPM BioVentures Parallel Fund, LP
MPM Asset Management Investors 1999 LLC
MPM BioVentures III-QP, L.P
MPM BioVentures III, L.P.
MPM BioVentures III Parallel Fund, LP
MPM Asset Management Investors 2004 BVIII LLC
MPM BioVentures III GmbH & Co. Beteiligungs KG
MPM BioVentures I, L.P.
MPM BioVentures I LLC
BAB BioVentures L.P.
BAB BioVentures, N.V.
MPM BioVentures III GP, L.P.
MPM BioVentures III LLC
Ansbert Gadicke
Luke Evnin
Nicholas Galakatos
Michael Steinmetz
Kurt Wheeler
Nicholas Simon III
Dennis Henner
  (b)   Address of Principal Business Office or, if none, Residence
c/o MPM Capital L.P.
The John Hancock Tower
200 Clarendon Street, 54th Floor
Boston, MA 02116
  (c)   Citizenship
All entities were organized in Delaware, except MPM BioVentures III GmbH & Co Beteiligungs KG which was organized in Germany and BAB BioVentures, N.V which was organized in the Netherland Antilles. All individuals are United States citizens.
  (d)   Title of Class of Securities
Common Stock
  (e)   CUSIP Number
71715N 10 6

Page 23 of 34


 

Item 3.   If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
Not applicable
Item 4. Ownership
  (a)   Amount Beneficially Owned:
         
BB BioVentures, LP
    0  
MPM BioVentures Parallel Fund, LP
    0  
MPM Asset Management Investors 1999 LLC
    0  
MPM BioVentures III-QP, L.P
    0  
MPM BioVentures III, L.P.
    0  
MPM BioVentures III Parallel Fund, LP
    0  
MPM Asset Management Investors 2004 BVIII LLC
    0  
MPM BioVentures III GmbH & Co. Beteiligungs KG
    0  
MPM BioVentures I, L.P.
    0  
MPM BioVentures I LLC
    0  
BAB BioVentures L.P.
    0  
BAB BioVentures, N.V.
    0  
MPM BioVentures III GP, L.P.
    0  
MPM BioVentures III LLC
    0  
Ansbert Gadicke
    0  
Luke Evnin
    0  
Michael Steinmetz
    0  
Kurt Wheeler
    0  
Nicholas Galakatos
    0  
Dennis Henner
    0  
Nicholas Simon III
    0  
  (b)   Percent of Class:
         
BB BioVentures, LP
    0 %
MPM BioVentures Parallel Fund, LP
    0 %
MPM Asset Management Investors 1999 LLC
    0 %
MPM BioVentures III-QP, L.P
    0 %
MPM BioVentures III, L.P.
    0 %
MPM BioVentures III Parallel Fund, LP
    0 %
MPM Asset Management Investors 2004 BVIII LLC
    0 %
MPM BioVentures III GmbH & Co. Beteiligungs KG
    0 %
MPM BioVentures I, L.P.
    0 %

Page 24 of 34


 

         
MPM BioVentures I LLC
    0 %
BAB BioVentures L.P.
    0 %
BAB BioVentures, N.V.
    0 %
MPM BioVentures III GP, L.P.
    0 %
MPM BioVentures III LLC
    0 %
Ansbert Gadicke
    0 %
Luke Evnin
    0 %
Michael Steinmetz
    0 %
Kurt Wheeler
    0 %
Nicholas Galakatos
    0 %
Dennis Henner
    0 %
Nicholas Simon III
    0 %
  (c)   Number of shares as to which the person has:
  (i)   Sole power to vote or to direct the vote
         
BB BioVentures, LP
    0  
MPM BioVentures Parallel Fund, LP
    0  
MPM Asset Management Investors 1999 LLC
    0  
MPM BioVentures III-QP, L.P
    0  
MPM BioVentures III, L.P.
    0  
MPM BioVentures III Parallel Fund, LP
    0  
MPM Asset Management Investors 2004 BVIII LLC
    0  
MPM BioVentures III GmbH & Co. Beteiligungs KG
    0  
MPM BioVentures I, L.P.
    0  
MPM BioVentures I LLC
    0  
BAB BioVentures L.P.
    0  
BAB BioVentures, N.V.
    0  
MPM BioVentures III GP, L.P.
    0  
MPM BioVentures III LLC
    0  
Ansbert Gadicke
    0  
Luke Evnin
    0  
Michael Steinmetz
    0  
Kurt Wheeler
    0  
Nicholas Galakatos
    0  
Dennis Henner
    0  
Nicholas Simon III
    0  
  (ii)   Shared power to vote or to direct the vote
         
BB BioVentures, LP
    0  
MPM BioVentures Parallel Fund, LP
    0  

Page 25 of 34


 

         
MPM Asset Management Investors 1999 LLC
    0  
MPM BioVentures III-QP, L.P
    0  
MPM BioVentures III, L.P.
    0  
MPM BioVentures III Parallel Fund, LP
    0  
MPM Asset Management Investors 2004 BVIII LLC
    0  
MPM BioVentures III GmbH & Co. Beteiligungs KG
    0  
MPM BioVentures I, L.P.
    0  
MPM BioVentures I LLC
    0  
BAB BioVentures L.P.
    0  
BAB BioVentures, N.V.
    0  
MPM BioVentures III GP, L.P.
    0  
MPM BioVentures III LLC
    0  
Ansbert Gadicke
    0  
Luke Evnin
    0  
Michael Steinmetz
    0  
Kurt Wheeler
    0  
Nicholas Galakatos
    0  
Dennis Henner
    0  
Nicholas Simon III
    0  
  (iii)   Sole power to dispose or to direct the disposition of
         
BB BioVentures, LP
    0  
MPM BioVentures Parallel Fund, LP
    0  
MPM Asset Management Investors 1999 LLC
    0  
MPM BioVentures III-QP, L.P
    0  
MPM BioVentures III, L.P.
    0  
MPM BioVentures III Parallel Fund, LP
    0  
MPM Asset Management Investors 2004 BVIII LLC
    0  
MPM BioVentures III GmbH & Co. Beteiligungs KG
    0  
MPM BioVentures I, L.P.
    0  
MPM BioVentures I LLC
    0  
BAB BioVentures L.P.
    0  
BAB BioVentures, N.V.
    0  
MPM BioVentures III GP, L.P.
    0  
MPM BioVentures III LLC
    0  
Ansbert Gadicke
    0  
Luke Evnin
    0  
Michael Steinmetz
    0  

Page 26 of 34


 

         
Kurt Wheeler
    0  
Nicholas Galakatos
    0  
Dennis Henner
    0  
Nicholas Simon III
    0  
  (iv)   Shared power to dispose or to direct the disposition of
         
BB BioVentures, LP
    0  
MPM BioVentures Parallel Fund, LP
    0  
MPM Asset Management Investors 1999 LLC
    0  
MPM BioVentures III-QP, L.P
    0  
MPM BioVentures III, L.P.
    0  
MPM BioVentures III Parallel Fund, LP
    0  
MPM Asset Management Investors 2004 BVIII LLC
    0  
MPM BioVentures III GmbH & Co. Beteiligungs KG
    0  
MPM BioVentures I, L.P.
    0  
MPM BioVentures I LLC
    0  
BAB BioVentures L.P.
    0  
BAB BioVentures, N.V.
    0  
MPM BioVentures III GP, L.P.
    0  
MPM BioVentures III LLC
    0  
Ansbert Gadicke
    0  
Luke Evnin
    0  
Michael Steinmetz
    0  
Kurt Wheeler
    0  
Nicholas Galakatos
    0  
Dennis Henner
    0  
Nicholas Simon III
    0  
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following þ.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
     Not Applicable
Item 7.   Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
     Not Applicable

Page 27 of 34


 

Item 8. Identification and Classification of Members of the Group
     Not Applicable
Item 9. Notice of Dissolution of a Group
     Not Applicable
Item 10. Certification
     Not Applicable

Page 28 of 34


 

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: August 27, 2008

         
  BB BIOVENTURES, L.P.
 
 
  By:   BAB BioVentures L.P.,    
    its General Partner   
       
 
     
  By:   BAB BioVentures N.V.,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  MPM ASSET MANAGEMENT INVESTORS 1999 LLC
 
 
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  MPM BIOVENTURES III, L.P.
 
 
  By:   MPM BioVentures III GP, L.P.,    
    its General Partner   
       
 
     
  By:   MPM BioVentures III LLC,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Series A Member   
 
     
     
     
     
 
         
  MPM BIOVENTURES PARALLEL FUND, L.P.
 
 
  By:   MPM BioVentures I, LP,    
    its General Partner   
       
 
     
  By:   MPM BioVentures I LLC,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  MPM BIOVENTURES III-QP, L.P.
 
 
  By:   MPM BioVentures III GP, L.P.,    
    its General Partner   
       
 
     
  By:   MPM BioVentures III LLC,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Series A Member   
 
  MPM BIOVENTURES III GMBH & CO.
     BETEILIGUNGS KG
 
 
  By:   MPM BioVentures III GP, L.P.,    
    in its capacity as the Managing Limited Partner   
       
 
     
  By:   MPM BioVentures III LLC,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Series A Member   
 


Page 29 of 34


 

         
  MPM BIOVENTURES III PARALLEL FUND, L.P.
 
 
  By:   MPM BioVentures III GP, L.P.,    
    its General Partner   
       
 
     
  By:   MPM BioVentures III LLC,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Series A Member
 
 
 
  MPM BIOVENTURES I, L.P.
 
 
  By:   MPM BioVentures I LLC,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  BAB BIOVENTURES, L.P.
 
 
  By:   BAB BioVentures, N.V.    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  MPM BIOVENTURES III GP, L.P.
 
 
  By:   MPM BioVentures III LLC,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Series A Member   
 
     
  By:   /s/ Ansbert Gadicke    
    Name:   Ansbert Gadicke   
       
 
     
  By:   /s/ Michael Steinmetz    
    Name:   Michael Steinmetz   
       
 
         
  MPM ASSET MANAGEMENT INVESTORS 2004
    BVIII LLC
 
 
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  MPM BIOVENTURES I LLC
 
 
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  BAB BIOVENTURES, N.V.
 
 
  By:   /s/ Luke Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  MPM BIOVENTURES IIII LLC
 
 
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Series A Member   
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
       
 
     
  By:   /s/ Kurt Wheeler    
    Name:   Kurt Wheeler   
       
 
     
     
     
     
 


Page 30 of 34


 

         
     
  By:   /s/ Nicholas Galakatos    
    Name: Nicholas Galakatos   
 
     
  By:   /s/ Nicholas Simon III    
    Name:   Nicholas Simon III   
       
 
         
     
  By:   /s/ Dennis Henner    
    Name:   Dennis Henner   
       
 


EXHIBITS
A: Joint Filing Agreement

Page 31 of 34


 

EXHIBIT A
JOINT FILING AGREEMENT
     In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Pharmasset, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.
     In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 27th day of August, 2008.

         
  BB BIOVENTURES, L.P.
 
 
  By:   BAB BioVentures L.P.,    
    its General Partner   
       
 
     
  By:   BAB BioVentures N.V.,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  MPM ASSET MANAGEMENT INVESTORS 1999 LLC
 
 
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  MPM BIOVENTURES III, L.P.
 
 
  By:   MPM BioVentures III GP, L.P.,    
    its General Partner   
       
 
     
  By:   MPM BioVentures III LLC,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Series A Member   
 
         
  MPM BIOVENTURES PARALLEL FUND, L.P.
 
 
  By:   MPM BioVentures I, LP,    
    its General Partner   
       
 
     
  By:   MPM BioVentures I LLC,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  MPM BIOVENTURES III-QP, L.P.
 
 
  By:   MPM BioVentures III GP, L.P.,    
    its General Partner   
       
 
     
  By:   MPM BioVentures III LLC,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Series A Member   
 
  MPM BIOVENTURES III GMBH & CO.
    BETEILIGUNGS KG
 
 
  By:   MPM BioVentures III GP, L.P.,    
    in its capacity as the Managing Limited Partner   
       
 
     
  By:   MPM BioVentures III LLC,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Series A Member   
 


Page 32 of 34


 

         
  MPM BIOVENTURES III PARALLEL FUND, L.P.
 
 
  By:   MPM BioVentures III GP, L.P.,    
    its General Partner   
       
 
     
  By:   MPM BioVentures III LLC,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Series A Member    
 
  MPM BIOVENTURES I, L.P.
 
 
  By:   MPM BioVentures I LLC,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  BAB BIOVENTURES, L.P.
 
 
  By:   BAB BioVentures, N.V.    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  MPM BIOVENTURES III GP, L.P.
 
 
  By:   MPM BioVentures III LLC,    
    its General Partner   
       
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Series A Member   
 
     
  By:   /s/ Ansbert Gadicke    
    Name:   Ansbert Gadicke   
       
 
     
  By:   /s/ Michael Steinmetz    
    Name:   Michael Steinmetz   
       
 
         
  MPM ASSET MANAGEMENT INVESTORS 2004
    BVIII LLC
 
 
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  MPM BIOVENTURES I LLC
 
 
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  BAB BIOVENTURES, N.V.
 
 
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Manager   
 
  MPM BIOVENTURES IIII LLC
 
 
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
    Title:   Series A Member   
 
     
  By:   /s/ Luke B. Evnin    
    Name:   Luke B. Evnin   
       
 
     
  By:   /s/ Kurt Wheeler    
    Name:   Kurt Wheeler   
       
 


Page 33 of 34


 

         
     
  By:   /s/ Nicholas Galakatos    
    Name:   Nicholas Galakatos   
       
 
     
  By:   /s/ Nicholas Simon III    
    Name:   Nicholas Simon III   
       
 
         
     
  By:   /s/ Dennis Henner    
    Name:   Dennis Henner   
       
 


Page 34 of 34

-----END PRIVACY-ENHANCED MESSAGE-----